DK504384D0 - Stabil, vandig syreoploesning af cis-platin, egnet til injektion - Google Patents

Stabil, vandig syreoploesning af cis-platin, egnet til injektion

Info

Publication number
DK504384D0
DK504384D0 DK504384A DK504384A DK504384D0 DK 504384 D0 DK504384 D0 DK 504384D0 DK 504384 A DK504384 A DK 504384A DK 504384 A DK504384 A DK 504384A DK 504384 D0 DK504384 D0 DK 504384D0
Authority
DK
Denmark
Prior art keywords
injection
stable
solution
cis
platinum
Prior art date
Application number
DK504384A
Other languages
English (en)
Other versions
DK504384A (da
DK160806B (da
DK160806C (da
Inventor
Alfred James Nijkerk
Original Assignee
Limited Liability Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Limited Liability Company filed Critical Limited Liability Company
Publication of DK504384D0 publication Critical patent/DK504384D0/da
Publication of DK504384A publication Critical patent/DK504384A/da
Publication of DK160806B publication Critical patent/DK160806B/da
Application granted granted Critical
Publication of DK160806C publication Critical patent/DK160806C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
DK504384A 1983-10-24 1984-10-23 Stabil, vandig syreoploesning af cis-platin egnet til injektion og fremgangsmaade til fremstilling heraf DK160806C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8303657 1983-10-24
NL8303657A NL8303657A (nl) 1983-10-24 1983-10-24 Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.

Publications (4)

Publication Number Publication Date
DK504384D0 true DK504384D0 (da) 1984-10-23
DK504384A DK504384A (da) 1985-04-25
DK160806B DK160806B (da) 1991-04-22
DK160806C DK160806C (da) 1991-10-07

Family

ID=19842603

Family Applications (1)

Application Number Title Priority Date Filing Date
DK504384A DK160806C (da) 1983-10-24 1984-10-23 Stabil, vandig syreoploesning af cis-platin egnet til injektion og fremgangsmaade til fremstilling heraf

Country Status (11)

Country Link
EP (1) EP0143478B1 (da)
JP (1) JPS60172923A (da)
AT (1) ATE28402T1 (da)
AU (1) AU576204B2 (da)
DE (1) DE3464849D1 (da)
DK (1) DK160806C (da)
ES (1) ES9300011A1 (da)
FI (1) FI78837C (da)
IL (1) IL72829A (da)
NL (1) NL8303657A (da)
NO (1) NO165277C (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83380A (en) * 1987-07-30 1991-04-15 Teva Pharma Stable aqueous cisplatin solutions
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
CA2122342A1 (en) * 1992-09-04 1994-03-17 Hironori Kawabata Pharmaceutical composition
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP2185559A1 (en) 2007-08-03 2010-05-19 Boehringer Ingelheim International GmbH Crystalline form of a dihydropteridione derivative
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
JP2016525532A (ja) 2013-07-26 2016-08-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 骨髄異形成症候群の処置
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4310515A (en) * 1978-05-30 1982-01-12 Bristol-Myers Company Pharmaceutical compositions of cisplatin
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations
US4426372A (en) * 1980-08-08 1984-01-17 Regents Of The University Of Minnesota Inhibition of undesired effects of platinum(II) compounds
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Also Published As

Publication number Publication date
ES9300011A1 (es) 1993-10-16
NO844225L (no) 1985-04-25
AU3226984A (en) 1985-06-13
FI78837C (fi) 1989-10-10
DK504384A (da) 1985-04-25
NL8303657A (nl) 1985-05-17
EP0143478A1 (en) 1985-06-05
NO165277C (no) 1991-01-30
EP0143478B1 (en) 1987-07-22
IL72829A0 (en) 1984-11-30
DE3464849D1 (en) 1987-08-27
IL72829A (en) 1986-09-30
FI78837B (fi) 1989-06-30
ATE28402T1 (de) 1987-08-15
AU576204B2 (en) 1988-08-18
JPS60172923A (ja) 1985-09-06
DK160806B (da) 1991-04-22
FI843286A0 (fi) 1984-08-20
DK160806C (da) 1991-10-07
FI843286A (fi) 1985-04-25
NO165277B (no) 1990-10-15

Similar Documents

Publication Publication Date Title
DK504384D0 (da) Stabil, vandig syreoploesning af cis-platin, egnet til injektion
ES2004931A6 (es) Un procedimiento para preparar un concentrado transparente y estable frente al almacenamiento y un procedimiento para fabricar un desinfectante
ATE15853T1 (de) Methode zur herstellung eines gelierten nahrungsmittels.
DE69016087T2 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
ATE12257T1 (de) Waessrige cholesterin-standardloesung und verfahren zu ihrer herstellung.
KR850001228A (ko) (8s)-8-플루오로에리트로마이신의 제조방법
KR920009689A (ko) 안정화 이산화염소 수용액의 제조방법
ATE36516T1 (de) Reinigung von 4-fluor-4'-hydroxy-benzophenon.
JPS5582128A (en) Preparation of making film containing enzyme
KR890006663A (ko) 칼슘 5'-리보누클레오티드의 제조방법
KR870003009A (ko) 수성 클로로옥사이드-용액의 제조방법
ATE82269T1 (de) Verfahren zur herstellung von 1-pyrazolinen.
ES468322A1 (es) Procedimiento para la preparacion de un derivado del benci- clan
SU1690317A1 (ru) Способ получения йодноватой кислоты
TH2985B (th) สารละลายเข้มข้นมีเสถียรภาพประกอบด้วยซิลเวอร์ ซึ่งเมื่อเติมลงในไฮโดรเยนเปอร์ออกไซด์จะให้สารใช้ฆ่าเชื้อโรค
SU1744946A1 (ru) Способ получения смеси изомеров 9-(2-хлорэтил)-7-нитрозо-l-гомоцитруллина и 9-(2-хлорэтил)-9-нитрозо-l-гомоцитруллина
TH4568A (th) สารละลายเข้มข้นมีเสถียรภาพประกอบด้วยซิลเวอร์ ซึ่งเมื่อเติมลงในไฮโดรเยนเปอร์ออกไซด์จะให้สารใช้ฆ่าเชื้อโรค
SU1840597A1 (ru) Способ получения бис-(хлороксимино)-ацетона

Legal Events

Date Code Title Description
PUP Patent expired